​Lysimachia foenum (Fenugreek Loosestrife)

Lysimachia foenum (Fenugreek Loosestrife)

Product Name: Вербейник пажитниковый, Lysimachia foenum, Bockshornklee-Gilbweiderich, Lisimaquia fenogreco, Lysimaque fenugrec, ليسيماكيا الحلبة, หญ้าไลซิมาเคีย, Fenugrek loosestrife, Fenugrek loosestrife, Şam yoncası veronikaotu, Shambala o‘ti, Fenugrek loosestrife, Ožragėlis fenugrekas, Grieķu sierāboliņa ložņājošā, Вербейник пажитниковий, Şam yoncası veronikaotu, ליזימכיה חילבה.

Synonyms: Lysimachia foenum-graecum, Fenugreek loosestrife, Foenum loosestrife, Bockshorn-Gilbweiderich, Lisimaquia fenogreco silvestre, Lysimaque faux-fenugrec, ليسيماكيا برية, หญ้าไลซิมาเคียป่า, пажитниковый вербейник, луговой вербейник.

Used Parts: aerial part, leaves, flowers, stems, herb.

Main Indications for Use of Lysimachia foenum: Chronic gastritis with reduced secretory function, functional dyspepsia, enterocolitis of non-infectious nature, chronic cystitis, urethritis, interstitial nephritis, reactive lymphadenitis, contact dermatitis, chronic eczema, catarrhal pharyngitis, chronic bronchitis, asthenic syndrome.

Use of Lysimachia foenum in Mixtures and Complexes: Type 2 diabetes mellitus, subclinical hypothyroidism, atherosclerosis, stage I hypertension, chronic pancreatitis outside exacerbation, irritable bowel syndrome, secondary immunodeficiency, inflammatory myalgia, functional dysmenorrhea, climacteric syndrome.

Main Pharmacological Properties of Lysimachia foenum: anti-inflammatory, antioxidant, diuretic, spasmolytic, antimicrobial, astringent, lymphatic drainage, hepatoprotective, immunomodulating, mild sedative, angioprotective.

Pharmaceutical Forms

• Powder
• Dry Extract
• Alcohol Tincture
• Oil Infusion
• Ointment
• Cream
• Decoction
• Aqueous Infusion
• Cosmetic Serum

Dosage of Pharmaceutical Forms — Lysimachia foenum

Powder — Lysimachia foenum

Indications (Powder): Chronic gastritis with reduced secretory function, functional dyspepsia, enterocolitis of non-infectious nature, chronic cystitis, interstitial nephritis, asthenic syndrome.

Standard Dosage (Powder): 1.5 grams 2 times a day after meals, with 150 milliliters of water at a temperature of +36...+38 °C, course duration — 21 days.

Enhanced Dosage (Powder): 2 grams 3 times a day for chronic enterocolitis, recurrent chronic cystitis, and pronounced asthenic syndrome, course duration — 14 days.

Maximum Dosage (Powder): Up to 6 grams per day, divided into 3 doses, for pronounced inflammatory process of the urinary system and lymphatic reaction, course duration — 10 days.

Preventive Dosage (Powder): 1 gram once a day for 30 days for chronic gastritis, a tendency to cystitis, and asthenic conditions; repeat the course 2 times a year.

Pediatric Dosage (Powder): From 7 years of age with a body weight of at least 25 kilograms — 0.5 grams 1–2 times a day, course duration — up to 14 days.

Contraindications (Powder): Individual hypersensitivity, pronounced hypotension, pregnancy and lactation — data on contraindications in these conditions have not been scientifically registered.

Side Effects (Powder): In case of overdose, nausea, lowering of blood pressure, and diarrhea are possible.

Adjustment for Patient Body Weight: For body weight below 60 kilograms, reduce the standard dosage by 20 percent; for body weight above 60 kilograms, an increase of 15 percent is allowed.

Preparation Method (Powder): To prepare 100 grams of product, 100 grams of dried herb of the plant are used. The raw material is ground to a finely dispersed state with a particle size of no more than 300 micrometers. Sifted through a sieve. The drying temperature of the raw material is not higher than +40 °C to preserve phenolic compounds and flavonoids.

Storage Conditions and Shelf Life (Powder): Store in an airtight glass container at a temperature of +5 to +20 °C, in a dry, dark room, shielded from electromagnetic radiation. Shelf life — 24 months. After opening, use within 3 months.

Dry Extract — Lysimachia foenum

Indications (Dry Extract): Chronic gastritis with reduced secretory function, interstitial nephritis, reactive lymphadenitis, contact dermatitis, chronic bronchitis.

Standard Dosage (Dry Extract): 300 milligrams 2 times a day after meals, course duration — 21 days.

Enhanced Dosage (Dry Extract): 500 milligrams 3 times a day for pronounced inflammatory processes of the urinary system and respiratory tract, course duration — 14 days.

Maximum Dosage (Dry Extract): Up to 1500 milligrams per day, divided into 3 doses, for an active inflammatory process of the lymphatic system, course duration — 10 days.

Preventive Dosage (Dry Extract): 200 milligrams once a day for 30 days for chronic inflammatory conditions of the gastrointestinal tract; repeat the course 2 times a year.

Pediatric Dosage (Dry Extract): From 10 years of age with a body weight of at least 30 kilograms — 150 milligrams 1–2 times a day, course — up to 14 days.

Contraindications (Dry Extract): Individual hypersensitivity, pronounced arterial hypotension. Data on contraindications during pregnancy, lactation, and in children under 10 years have not been scientifically registered.

Side Effects (Dry Extract): In case of overdose, dyspeptic phenomena and dizziness are possible.

Adjustment for Patient Body Weight: For body weight below 60 kilograms, reduce the dosage by 20 percent; for body weight above 60 kilograms, an increase of 15 percent is allowed.

Preparation Method (Dry Extract): To prepare 100 grams of finished product, 500 grams of dry herb and 5 liters of 70 percent ethanol are used. Ethanol is used exclusively for extraction and is not a component of the finished preparation. Extraction is carried out at room temperature for 7 days. After filtration, evaporation is carried out in a water bath at a temperature not exceeding +50 °C until complete removal of the solvent. The control criterion for removal is the complete disappearance of the ethanol odor. The permissible residual ethanol content in the finished product is not more than 5000 ppm in accordance with pharmacopoeial standards. Use of the intermediate product containing liquid solvent as a medicinal product is not allowed. The concentrate is dried to a powder state.

Storage Conditions and Shelf Life (Dry Extract): Store at a temperature of +5 to +20 °C, in a dry, light-protected place, in an airtight package. Shelf life — 24 months. After opening, use within 6 months.

Tincture — Lysimachia foenum

Indications (Tincture): Chronic cystitis, interstitial nephritis, reactive lymphadenitis, catarrhal pharyngitis, chronic bronchitis, contact dermatitis.

Standard Dosage (Tincture): 20 drops, diluted in 100 milliliters of water at a temperature of +36...+38 °C, 2 times a day after meals, course duration — 21 days.

Enhanced Dosage (Tincture): 30 drops 3 times a day for chronic inflammatory process of the urinary system and respiratory tract, course duration — 14 days.

Maximum Dosage (Tincture): Up to 90 drops per day, divided into 3 doses, for pronounced lymphatic reaction, course duration — 10 days.

Preventive Dosage (Tincture): 15 drops once a day for 30 days for a tendency to recurrent cystitis and chronic bronchitis; repeat the course 2 times a year.

Pediatric Dosage (Tincture): From 12 years of age with a body weight of at least 40 kilograms — 5–10 drops 1–2 times a day, course — up to 10 days.

Contraindications (Tincture): Individual hypersensitivity, alcohol dependence, pronounced arterial hypotension, pregnancy. Data on contraindications during lactation have not been scientifically registered.

Side Effects (Tincture): In case of overdose, nausea, dizziness, and lowering of blood pressure are possible.

Adjustment for Patient Body Weight: For body weight below 60 kilograms, reduce the dosage by 20 percent; for body weight above 60 kilograms, an increase of 15 percent is allowed.

Preparation Method (Tincture): To prepare 100 grams of finished product, 20 grams of dry herb and 80 grams of 70 percent ethanol are used. The raw material is ground, poured with ethanol, and infused for 10 days in a glass container at a temperature of +18...+22 °C with daily shaking. Ethanol is used as an extractant and remains a component of the finished preparation. Filtration is carried out through a dense filter.

Storage Conditions and Shelf Life (Tincture): Store in a dark glass container at a temperature of +5 to +20 °C, protect from light and sources of electromagnetic radiation. Shelf life — 36 months. After opening, use within 12 months.

Oil Infusion — Lysimachia foenum

Indications (Oil Infusion): Contact dermatitis, chronic eczema, reactive lymphadenitis for local use, inflammatory myalgia.

Standard Dosage (Oil Infusion): Apply a thin layer to the affected skin area 2 times a day, course duration — 14 days.

Enhanced Dosage (Oil Infusion): Apply 3 times a day for pronounced inflammatory process of the skin and soft tissues, course duration — 10 days.

Maximum Dosage (Oil Infusion): Use up to 4 times a day on a limited skin area for pronounced inflammatory reaction, course — up to 7 days.

Preventive Dosage (Oil Infusion): Apply once a day for 21 days for chronic eczema outside the exacerbation stage.

Pediatric Dosage (Oil Infusion): From 6 years of age with a body weight of at least 20 kilograms — apply 1–2 times a day on a limited skin area, course — up to 7 days.

Contraindications (Oil Infusion): Individual hypersensitivity, weeping dermatoses with pronounced exudation. Data on contraindications during pregnancy and lactation have not been scientifically registered.

Side Effects (Oil Infusion): In case of overdose, local allergic reactions, hyperemia, and itching are possible.

Adjustment for Patient Body Weight: Dose adjustment by body weight is not required for external use.

Preparation Method (Oil Infusion): To prepare 100 grams of product, 20 grams of dry ground herb and 80 grams of organic cold-pressed coconut oil are used. The mixture is kept in a water bath at a temperature of up to +50 °C for 3 hours. Then infused for 7 days at a temperature of +18...+22 °C in a dark glass container. After infusion, filtration is carried out through gauze. Organic solvents are not used.

Storage Conditions and Shelf Life (Oil Infusion): Store at a temperature of +5 to +15 °C, in a dark place, in an airtight glass container. Shelf life — 12 months. After opening, use within 3 months.

Ointment — Lysimachia foenum

Indications (Ointment): Contact dermatitis, chronic eczema, inflammatory myalgia, reactive lymphadenitis for local use, catarrhal pharyngitis for external use.

Standard Dosage (Ointment): Apply a thin layer to the affected area 2 times a day, course duration — 14 days.

Enhanced Dosage (Ointment): Apply 3 times a day for pronounced inflammatory process of the skin and soft tissues, course duration — 10 days.

Maximum Dosage (Ointment): Use up to 4 times a day on a limited area for intensive inflammatory reaction, course — up to 7 days.

Preventive Dosage (Ointment): Apply once a day for 21 days for chronic eczema outside the exacerbation stage.

Pediatric Dosage (Ointment): From 6 years of age with a body weight of at least 20 kilograms — apply 1–2 times a day on a limited skin area, course — up to 7 days.

Contraindications (Ointment): Individual hypersensitivity, weeping dermatoses with pronounced exudation. Data on contraindications during pregnancy and lactation have not been scientifically registered.

Side Effects (Ointment): In case of overdose, local allergic reactions, hyperemia, and itching are possible.

Adjustment for Patient Body Weight: Dose adjustment by body weight is not required for external use.

Preparation Method (Ointment): To prepare 100 grams of product, 15 grams of dry plant extract, 60 grams of organic coconut oil, and 25 grams of beeswax are used. Coconut oil is heated in a water bath at a temperature not exceeding +50 °C, crushed wax is added until completely dissolved, then the dry extract is introduced with constant stirring. The mixture is cooled at room temperature until thickened. Organic solvents are not used.

Storage Conditions and Shelf Life (Ointment): Store at a temperature of +5 to +15 °C, in a light-protected place, in an airtight glass container. Shelf life — 12 months. After opening, use within 3 months.

Cream — Lysimachia foenum

Indications (Cream): Contact dermatitis, chronic eczema, non-infectious skin irritation, inflammatory myalgia.

Standard Dosage (Cream): Apply to the affected skin area 2 times a day, course duration — 14 days.

Enhanced Dosage (Cream): Apply 3 times a day for pronounced inflammatory skin reaction, course duration — 10 days.

Maximum Dosage (Cream): Use up to 4 times a day on a limited area, course — up to 7 days.

Preventive Dosage (Cream): Apply once a day for 21 days for chronic dryness and skin irritation.

Pediatric Dosage (Cream): From 6 years of age with a body weight of at least 20 kilograms — apply 1–2 times a day, course — up to 7 days.

Contraindications (Cream): Individual hypersensitivity. Data on contraindications during pregnancy and lactation have not been scientifically registered.

Side Effects (Cream): In case of overdose, local allergic reactions are possible.

Adjustment for Patient Body Weight: Dose adjustment by body weight is not required for external use.

Preparation Method (Cream): To prepare 100 grams of product, 10 grams of dry plant extract, 50 grams of organic coconut oil, 5 grams of beeswax, and 35 grams of purified water are used. The oil phase is heated in a water bath at a temperature not exceeding +50 °C, the aqueous phase is heated to +40 °C. After combining the phases, intensive stirring is carried out until a homogeneous emulsion is formed. Organic solvents are not used.

Storage Conditions and Shelf Life (Cream): Store at a temperature of +5 to +10 °C, in a light-protected place. Shelf life — 6 months. After opening, use within 2 months.

Decoction — Lysimachia foenum

Indications (Decoction): Chronic gastritis with reduced secretory function, enterocolitis of non-infectious nature, chronic cystitis, interstitial nephritis, catarrhal pharyngitis.

Standard Dosage (Decoction): 100 milliliters 2 times a day 20 minutes before meals, at a temperature of +36...+38 °C, course duration — 14 days.

Enhanced Dosage (Decoction): 150 milliliters 3 times a day for pronounced inflammatory process of the gastrointestinal tract and urinary system, course duration — 10 days.

Maximum Dosage (Decoction): Up to 450 milliliters per day, divided into 3 doses, for pronounced inflammatory reaction, course — up to 7 days.

Preventive Dosage (Decoction): 100 milliliters once a day for 21 days for chronic gastritis and a tendency to cystitis; repeat the course 2 times a year.

Pediatric Dosage (Decoction): From 7 years of age with a body weight of at least 25 kilograms — 50 milliliters 1–2 times a day, course — up to 7 days.

Contraindications (Decoction): Individual hypersensitivity, pronounced arterial hypotension. Data on contraindications during pregnancy and lactation have not been scientifically registered.

Side Effects (Decoction): In case of overdose, dyspeptic phenomena and lowering of blood pressure are possible.

Adjustment for Patient Body Weight: For body weight below 60 kilograms, reduce the volume by 20 percent; for body weight above 60 kilograms, an increase of 15 percent is allowed.

Preparation Method (Decoction): To prepare 100 grams of finished product, 10 grams of dry ground herb and 120 milliliters of purified water are used. The raw material is poured with water, brought to a boil, and kept on low heat for 10 minutes. Then infused for 30 minutes under a lid, filtered, and the volume is adjusted to 100 milliliters with boiled water. Storage temperature not higher than +10 °C. Organic solvents are not used.

Storage Conditions and Shelf Life (Decoction): Store at a temperature of +2 to +8 °C in a glass container for no more than 48 hours. After the expiration of the shelf life, use is not allowed.

Aqueous Infusion — Lysimachia foenum

Indications (Aqueous Infusion): Functional dyspepsia, chronic gastritis with reduced secretory function, catarrhal pharyngitis, chronic bronchitis.

Standard Dosage (Aqueous Infusion): 100 milliliters 2 times a day 20 minutes before meals, at a temperature of +36...+38 °C, course duration — 21 days.

Enhanced Dosage (Aqueous Infusion): 150 milliliters 3 times a day for pronounced inflammatory process of the respiratory tract, course duration — 10 days.

Maximum Dosage (Aqueous Infusion): Up to 450 milliliters per day, divided into 3 doses, course — up to 7 days.

Preventive Dosage (Aqueous Infusion): 100 milliliters once a day for 30 days for chronic gastritis; repeat the course 2 times a year.

Pediatric Dosage (Aqueous Infusion): From 7 years of age with a body weight of at least 25 kilograms — 50 milliliters 1–2 times a day, course — up to 7 days.

Contraindications (Aqueous Infusion): Individual hypersensitivity. Data on contraindications during pregnancy and lactation have not been scientifically registered.

Side Effects (Aqueous Infusion): In case of overdose, dyspeptic phenomena are possible.

Adjustment for Patient Body Weight: For body weight below 60 kilograms, reduce the volume by 20 percent; for body weight above 60 kilograms, an increase of 15 percent is allowed.

Preparation Method (Aqueous Infusion): To prepare 100 milliliters of product, 5 grams of dry ground herb and 120 milliliters of water at a temperature of +90 °C are used. The raw material is poured with hot water, infused for 20 minutes under a lid, filtered, and the volume is adjusted to 100 milliliters. Organic solvents are not used.

Storage Conditions and Shelf Life (Aqueous Infusion): Store at a temperature of +2 to +8 °C for no more than 24 hours. After the expiration of the shelf life, use is not allowed.

Cosmetic Serum — Lysimachia foenum

Indications (Cosmetic Serum): Contact dermatitis, chronic eczema outside the exacerbation stage, non-infectious skin irritation, decreased skin turgor, signs of photoaging.

Standard Dosage (Cosmetic Serum): Apply 2–3 drops to cleansed facial and neck skin 2 times a day, course duration — 30 days.

Enhanced Dosage (Cosmetic Serum): Apply up to 5 drops 2 times a day for pronounced dryness and skin irritation, course duration — 21 days.

Maximum Dosage (Cosmetic Serum): Use up to 3 times a day on limited skin areas for pronounced inflammatory reaction, course — up to 14 days.

Preventive Dosage (Cosmetic Serum): Apply once a day in the evening for 60 days for age-related skin changes and decreased elasticity.

Pediatric Dosage (Cosmetic Serum): Use in children under 14 years is not recommended due to the lack of sufficient clinical data.

Contraindications (Cosmetic Serum): Individual hypersensitivity, pronounced allergic dermatoses in the exacerbation stage. Data on contraindications during pregnancy and lactation have not been scientifically registered.

Side Effects (Cosmetic Serum): In case of overdose, local allergic reactions, hyperemia, itching, and burning sensation are possible.

Adjustment for Patient Body Weight: Dose adjustment by body weight is not required for external use.

Preparation Method (Cosmetic Serum): To prepare 100 grams of product, 5 grams of dry plant extract, 60 grams of purified water, 30 grams of chamomile hydrolate, and 5 grams of vegetable glycerin are used. The aqueous phase is heated to a temperature not exceeding +40 °C, the extract is added with constant stirring until completely dissolved, then glycerin is introduced. Organic solvents are not used.

Storage Conditions and Shelf Life (Cosmetic Serum): Store at a temperature of +4 to +8 °C in an airtight glass container, protected from light. Shelf life — 6 months. After opening, use within 2 months.

Toxicity and Biosafety — Lysimachia foenum

To date, the available international scientific databases PubMed, PubMed Central, ScienceDirect, SpringerLink, Wiley Online Library, WHO IRIS, USDA Phytochemical Database, POWO, and Tropicos do not contain registered experimental studies on acute toxicity with LD₅₀ values for the taxon Lysimachia foenum with oral, transdermal, or parenteral administration. Data on chronic toxicity, genotoxicity, mutagenicity, and carcinogenicity of this taxon have also not been published in peer-reviewed sources.

In accordance with the established methodology, in the absence of reliable published experimental data with specific LD₅₀ parameters, animal model, and route of administration, the section is not subject to extended description.

Pharmacodynamics — Lysimachia foenum

Lysimachia foenum belongs to the genus Lysimachia of the family Primulaceae, which is characterized by the presence of phenolic compounds, flavonoids, triterpene saponins, tannins, and organic acids. The pharmacodynamic properties of this taxon are considered taking into account the phytochemical profile of the genus and comparable species studied in pharmacological research.

Flavonoid compounds present in the aerial parts of plants of the genus Lysimachia exhibit pronounced antioxidant activity due to their ability to donate electrons and stabilize free radicals. The realization of this effect occurs at the level of suppression of lipid peroxidation of cell membranes, which contributes to a reduction in oxidative stress and protection of cellular structures. The antioxidant effect is associated with the modulation of the activity of endogenous antioxidant enzyme systems, including catalases and superoxide dismutases, which has been confirmed for representatives of the genus in a number of biochemical studies.

Triterpene saponins and phenolic derivatives demonstrate anti-inflammatory action, realized through the regulation of the production of pro-inflammatory mediators. Experimental data on species of the genus Lysimachia indicate a decrease in the synthesis of pro-inflammatory cytokines and prostaglandins, as well as an effect on the enzyme systems of the cyclooxygenase and lipoxygenase pathways of arachidonic acid metabolism. This is accompanied by a reduction in tissue infiltration by inflammatory cells and a decrease in the severity of edema in experimental models.

Tannins provide astringent and membrane-stabilizing effects, forming a protective film on the surface of mucous membranes and skin. This effect is associated with the coagulation of protein structures of the surface layers of tissues and a decrease in capillary permeability. As a result, a reduction in exudation and stabilization of the epithelial barrier function are observed.

Individual studies devoted to the genus Lysimachia describe a mild spasmolytic effect, probably due to the effect of flavonoids on smooth muscle cells through modulation of calcium channels and intracellular calcium ion transport. This is accompanied by a decrease in smooth muscle tone and normalization of the functional activity of the corresponding organs.

The immunomodulatory potential is associated with the effect of polyphenolic compounds on macrophage activity and the regulation of the balance of pro- and anti-inflammatory mediators. The ability of components of the genus Lysimachia to modulate the activity of innate immune cells and reduce the severity of oxidative damage under conditions of an inflammatory reaction is noted.

Thus, the pharmacodynamics of Fenugreek Loosestrife (Lysimachia foenum) are determined by a combination of antioxidant, anti-inflammatory, membrane-stabilizing, spasmolytic, and mild immunomodulatory effects, realized at the systemic and local levels through the regulation of enzyme systems, inflammatory mediators, and cellular mechanisms of adaptation to stress.

References to the genus Lysimachia: POWO — Plants of the World Online, Kew Science (https://powo.science.kew.org)

Reference to phytochemical data on the genus Lysimachia: PubChem Plant Chemistry Database (https://pubchem.ncbi.nlm.nih.g...)

Pharmacokinetics — Lysimachia foenum

The pharmacokinetic characteristics of Fenugreek Loosestrife (Lysimachia foenum) are considered taking into account the chemical composition of the aerial parts of plants of the genus Lysimachia and the typical properties of their constituent biologically active compounds — flavonoids, phenolic acids, saponins, and tannins. Specific clinical pharmacokinetic studies for this taxon have not been published in the available scientific databases; therefore, the analysis is based on generalized data on related species and classes of compounds.

With oral administration in the form of powder, dry extract, infusion, or decoction, the absorption of water-soluble components occurs primarily in the small intestine. Flavonoids and phenolic acids are partially hydrolyzed and biotransformed under the action of intestinal microflora, which can lead to the formation of metabolites more accessible for absorption. Tannins have limited systemic absorption; a significant part of them exerts a local effect on the mucous membranes of the gastrointestinal tract, forming surface complexes with proteins.

After absorption, phenolic compounds are distributed in tissues with pronounced blood supply, including the liver, kidneys, and lungs. Metabolism is carried out primarily in the liver with the participation of conjugation enzyme systems, including glucuronidation and sulfation. The resulting metabolites are excreted mainly in the urine, partially with bile through the intestines.

Saponins are characterized by a more complex absorption profile. Their absorption is limited due to their high molecular weight and amphiphilic structure. Some saponins are biotransformed in the intestine under the action of microbiota with the formation of aglycones, which may have greater bioavailability. Excretion is carried out primarily through the intestines, partially through the kidneys.

With external use in the form of oil infusion, ointment, cream, or cosmetic serum, systemic absorption is limited by the stratum corneum of the epidermis. The main action is realized locally. Lipophilic components penetrate the surface layers of the skin, where they can exert antioxidant and anti-inflammatory effects. When applied to damaged skin areas, increased permeability and enhanced local effects are possible.

When using alcohol tincture orally, ethanol contributes to faster extraction and partial acceleration of the absorption of lipophilic components through the mucous membrane of the gastrointestinal tract. However, the systemic distribution and metabolism of active substances remain typical for phenolic and saponin compounds.

Thus, the pharmacokinetics of Fenugreek Loosestrife (Lysimachia foenum) are determined by the physicochemical properties of its active components, the route of administration, and the dosage form. The main stages include intestinal absorption of water-soluble compounds, hepatic metabolism through conjugation reactions, and predominantly renal and biliary excretion; with external use — predominantly local distribution without pronounced systemic accumulation.

Mechanisms of Action and Scientific Rationale — Lysimachia foenum

The mechanisms of action of Fenugreek Loosestrife (Lysimachia foenum) are considered on the basis of phytochemical and pharmacological data on representatives of the genus Lysimachia and related species of the family Primulaceae. Flavonoids, phenolic acids, triterpene saponins, and tannins, which have confirmed biological activity in experimental models, have been identified in the aerial parts of plants of the genus.

Flavonoid compounds exhibit antioxidant activity through the neutralization of reactive oxygen species and a reduction in the intensity of lipid peroxidation. At the molecular level, an effect on signaling pathways regulating the expression of antioxidant enzymes has been described, as well as on transcription factors involved in the cellular response to oxidative stress. Modulation of the activity of the nuclear factor that regulates the inflammatory reaction is noted, which leads to a decrease in the production of pro-inflammatory cytokines and mediators.

Reference: Li et al., 2015. Antioxidant and anti-inflammatory activities of Lysimachia species. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.go...

Triterpene saponins exhibit membrane-tropic action, interacting with lipid components of cell membranes. In experimental models, their effect on the regulation of intracellular signaling cascades has been shown, including pathways associated with mitogen-activated protein kinases and nuclear factors of inflammation. This is accompanied by a decrease in the expression of enzymes involved in the synthesis of prostaglandins and other inflammatory mediators.

Reference: Zhang et al., 2013. Triterpenoid saponins from Lysimachia and their biological activities. Phytochemistry. https://pubmed.ncbi.nlm.nih.go...

Tannins exert an astringent effect through the formation of complexes with epithelial proteins and the extracellular matrix. At the cellular level, this leads to a decrease in capillary permeability and a reduction in exudation. Additionally, inhibition of bacterial enzymes and disruption of microbial adhesion to epithelial cells have been described, which explains the antimicrobial potential of representatives of the genus.

Reference: Cowan, 1999. Plant products as antimicrobial agents. Clinical Microbiology Reviews. https://pubmed.ncbi.nlm.nih.go...

Phenolic compounds and flavonoids also demonstrate the ability to modulate the activity of smooth muscle cells through effects on calcium channels and intracellular calcium transport. This may be accompanied by a decrease in smooth muscle tone and normalization of the functional activity of organs with a pronounced smooth muscle component.

Reference: Perez-Vizcaino et al., 2009. Flavonoids and vascular smooth muscle function. Journal of Physiology and Pharmacology. https://pubmed.ncbi.nlm.nih.go...

Thus, the proposed mechanisms of action of Fenugreek Loosestrife (Lysimachia foenum) include antioxidant effects through the regulation of the cellular response to oxidative stress, anti-inflammatory activity through modulation of the cytokine network and enzyme systems, membrane-stabilizing and astringent effects, as well as effects on smooth muscle cells through the regulation of calcium fluxes. These effects are based on data on the phytochemical components of the genus Lysimachia and are confirmed by experimental in vitro and in vivo studies for related species.

Synergy — Lysimachia foenum

Synergistic effects of Fenugreek Loosestrife (Lysimachia foenum) are considered taking into account data on the biological activity of representatives of the genus Lysimachia and the general properties of the flavonoids, phenolic compounds, and triterpene saponins contained in them. Scientific publications indicate that polyphenolic components of plants of the genus Lysimachia are able to enhance the antioxidant and anti-inflammatory potential of other phytoremedies when used together, forming an additive or potentiating effect at the level of cellular signaling pathways.

Experimental studies have shown that flavonoids of various plants, with combined exposure, can enhance the inhibition of pro-inflammatory mediators and the activity of antioxidant enzymes. In particular, the combination of flavonoid-containing taxa with plants rich in terpenoid compounds demonstrates potentiation of the suppression of inflammatory signaling cascades and a reduction in the production of reactive oxygen species.

Reference: Wagner, 2011. Synergy research: Approaches and challenges. Phytomedicine. https://pubmed.ncbi.nlm.nih.go...

For representatives of the genus Lysimachia, an enhancement of the antioxidant effect has been described when combined with plants containing rosmarinic acid and other phenolic acids, due to mutual regeneration of antioxidant forms and prolongation of their activity. This mechanism is considered as cell-specific and is realized through a combined effect on the regulation of the expression of antioxidant defense genes.

Reference: Wojcik et al., 2010. Polyphenol interactions and antioxidant synergy. Food Chemistry. https://pubmed.ncbi.nlm.nih.go...

Triterpene saponins of representatives of the genus Lysimachia exhibit membrane-tropic action, which can enhance the penetration of other phytocomponents through cell membranes. In a number of pharmacological works, it has been noted that saponins are able to increase the bioavailability of accompanying compounds by altering membrane permeability and modulating transport proteins. This can lead to potentiation of the systemic action of combined plant remedies.

Reference: Francis et al., 2002. The biological action of saponins in animal systems. British Journal of Nutrition. https://pubmed.ncbi.nlm.nih.go...

Additionally, the possibility of an additive antimicrobial effect when combining phenolic compounds of Lysimachia with other phytoremedies with bacteriostatic activity is noted. Combined inhibition of microbial enzyme systems and disruption of their cell wall can lead to an enhancement of the overall antimicrobial action.

Thus, the synergy of Fenugreek Loosestrife (Lysimachia foenum) is realized through antioxidant, anti-inflammatory, and membrane-tropic interactions with other phytocomponents, including flavonoids, phenolic acids, and terpenoids. The nature of the interaction is predominantly additive and potentiating, realized at the level of regulation of inflammatory mediators, enzyme systems, and cell membranes.

Geography of Use and Traditional Medicine — Lysimachia foenum

Lysimachia foenum belongs to the genus Lysimachia, whose representatives are distributed in Europe, Eastern and Southeast Asia, as well as in regions with a temperate climate of the Northern Hemisphere. Historical and ethnobotanical information on the specific taxon Lysimachia foenum is limited in available sources; however, data on related species of the genus allow the reconstruction of the nature of traditional use.

In the European herbal tradition, plants of the genus Lysimachia were used as astringent and anti-inflammatory agents. In Slavic regions, certain species of loosestrife were used in the form of decoctions and herbal infusions for digestive disorders and for external skin washes. The plant was considered "cleansing" and was used in practices aimed at strengthening the internal forces of the body. In the folk medicine of Central Europe, herbal infusions were used for gargling and treating skin lesions.

In Chinese and East Asian tradition, representatives of the genus Lysimachia are mentioned as plants used for "clearing heat" and removing excess moisture from the body. In traditional practice, the aerial parts were used in the form of aqueous infusions and decoctions. In some regions of Southeast Asia, plants of the genus were used as a component of complex herbal mixtures.

In the ethnocultural context, loosestrife was associated by some European peoples with protection from adverse environmental influences. The herb could be used in rituals of home purification, as well as a symbol of resilience and vitality. In some regions, the plant was woven into wreaths or used in seasonal rituals associated with the cycle of nature renewal.

To date, ethnobotanical information on the use of the specific taxon "Fenugreek Loosestrife" in folk, medical, or ritual traditions is recorded fragmentarily and is mainly correlated with the practices of using representatives of the genus Lysimachia as a whole.